| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7656240 | Revue Francophone des Laboratoires | 2011 | 7 Pages |
Abstract
Rapid progress has been achieved recently in the management of CLL. Chemoimmunotherapy including fludarabine, cyclophosphamide and rituximab is now the gold standard in all patients and effective treatments are also available in old patients, particularly those with co-morbidities.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Xavier Troussard, Michèle Malet, Edouard Cornet,